Literature DB >> 32918669

Acquired and modifiable cardiovascular risk factors in patients treated for cancer.

Gary S Beasley1,2, Jeffrey A Towbin3,4.   

Abstract

Cardiac mortality is the leading cause of death secondary to malignancy in survivors of cancer. The field of cardio-oncology is dedicated to identifying and, if possible, modifying risk factors that contribute to significant cardiac morbidity and mortality. Many risk factors for the development of cancer-related cardiotoxicity overlap with risk factors in cardiovascular disease such as hypertension, obesity, dyslipidemia, and diabetes among others. These risk factors are usually modifiable while others such as genetics, type of malignancy, and need for chemotherapy are less modifiable. This article summarizes acquired and modifiable risk factors in both pediatric and adult patients treated for cancer.

Entities:  

Keywords:  Cancer; Cardio-oncology; Cardiovascular disease; Chemotherapy related cardiotoxicity

Mesh:

Substances:

Year:  2020        PMID: 32918669     DOI: 10.1007/s11239-020-02273-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  18 in total

Review 1.  Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.

Authors:  Giuseppe Curigliano; Daniela Cardinale; Susan Dent; Carmen Criscitiello; Olexiy Aseyev; Daniel Lenihan; Carlo Maria Cipolla
Journal:  CA Cancer J Clin       Date:  2016-02-26       Impact factor: 508.702

2.  Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Authors:  Eric J Chow; Kasey J Leger; Neel S Bhatt; Daniel A Mulrooney; Colin J Ross; Sanjeev Aggarwal; Neha Bansal; Matthew J Ehrhardt; Saro H Armenian; Jessica M Scott; Borah Hong
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 3.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Carolyn Gotay; Andrew Ignaszewski; Andrew D Krahn; Margot K Davis; Christopher Franco; Arya Mani
Journal:  Atherosclerosis       Date:  2017-06-02       Impact factor: 5.162

Review 4.  Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction.

Authors:  Kirsten Rose-Felker; William L Border; Borah J Hong; Eric J Chow
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

Review 5.  Cardiovascular Toxicities in Pediatric Cancer Survivors.

Authors:  Thomas D Ryan; Rajaram Nagarajan; Justin Godown
Journal:  Cardiol Clin       Date:  2019-11       Impact factor: 2.213

Review 6.  Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.

Authors:  Vivek Narayan; Bonnie Ky
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

7.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08

8.  DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.

Authors:  Samira Abu Jhaisha; Esti W Widowati; Isao Kii; Rie Sonamoto; Stefan Knapp; Chrisovalantis Papadopoulos; Walter Becker
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 9.  Common risk factors for heart failure and cancer.

Authors:  Wouter C Meijers; Rudolf A de Boer
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 10.  Wnt Signaling in Cancer Metabolism and Immunity.

Authors:  Sara El-Sahli; Ying Xie; Lisheng Wang; Sheng Liu
Journal:  Cancers (Basel)       Date:  2019-06-28       Impact factor: 6.639

View more
  1 in total

Review 1.  Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology.

Authors:  Charles Porter; Tariq U Azam; Divyanshu Mohananey; Rohit Kumar; Jian Chu; Daniel Lenihan; Susan Dent; Sarju Ganatra; Gary S Beasley; Tochukwu Okwuosa
Journal:  JACC CardioOncol       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.